Clinical Trial Update: Preventive Treatment of OxaLiplatin Induced peripherAl neuRopathy in Adjuvant Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update for preventive treatment of oxaliplatin-induced peripheral neuropathy in adjuvant colorectal cancer; the study is terminated with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy
• Colorectal Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Egetis Therapeutics | Conditions: Colorectal Cancer, Chemotherapy-induced Peripheral Neuropathy | Phase 3 | Status: TERMINATED | Results posted: 2022-01-26